Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”

by Romain Eychenne, Michel Chérel, Férid Haddad, François Guérard, Jean-François Gestin
Published 2021-06-01

Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives

by Nicolas Lepareur, Nicolas Lepareur, Franck Lacœuille, Franck Lacœuille, Christelle Bouvry, Christelle Bouvry, François Hindré, François Hindré, Emmanuel Garcion, Emmanuel Garcion, Michel Chérel, Michel Chérel, Nicolas Noiret, Nicolas Noiret, Etienne Garin, Etienne Garin, F. F. Russ Knapp
Published 2019-06-01

Cell Tracking in Cancer Immunotherapy

by Justine Perrin, Marisa Capitao, Marie Mougin-Degraef, Marie Mougin-Degraef, François Guérard, Alain Faivre-Chauvet, Alain Faivre-Chauvet, Latifa Rbah-Vidal, Joëlle Gaschet, Yannick Guilloux, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Michel Chérel, Michel Chérel, Jacques Barbet
Published 2020-02-01

Rapamycin-Loaded Lipid Nanocapsules Induce Selective Inhibition of the mTORC1-Signaling Pathway in Glioblastoma Cells

by Delphine Séhédic, Loris Roncali, Amel Djoudi, Nela Buchtova, Sylvie Avril, Michel Chérel, Frank Boury, Franck Lacoeuille, François Hindré, Emmanuel Garcion
Published 2021-02-01

Long-Term Toxicity of 213Bi-Labelled BSA in Mice.

by Laëtitia Dorso, Edith Bigot-Corbel, Jérôme Abadie, Maya Diab, Sébastien Gouard, Frank Bruchertseifer, Alfred Morgenstern, Catherine Maurel, Michel Chérel, François Davodeau
Published 2016-01-01

Potential for Nuclear Medicine Therapy for Glioblastoma Treatment

by Clément Bailly, Clément Bailly, Aurelien Vidal, Coralie Bonnemaire, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Michel Chérel, Michel Chérel, Amandine Pallardy, Caroline Rousseau, Emmanuel Garcion, Franck Lacoeuille, Franck Lacoeuille, François Hindré, Samuel Valable, Myriam Bernaudin, Caroline Bodet-Milin, Caroline Bodet-Milin, Mickaël Bourgeois, Mickaël Bourgeois, Mickaël Bourgeois
Published 2019-07-01

Development of PET Radioligands Targeting COX-2 for Colorectal Cancer Staging, a Review of in vitro and Preclinical Imaging Studies

by Caroline Dagallier, Caroline Dagallier, François Avry, Yann Touchefeu, Yann Touchefeu, Frédéric Buron, Sylvain Routier, Michel Chérel, Nicolas Arlicot, Nicolas Arlicot, Nicolas Arlicot
Published 2021-06-01

Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture

by Clément Bailly, Caroline Bodet-Milin, Mickaël Bourgeois, Sébastien Gouard, Catherine Ansquer, Matthieu Barbaud, Jean-Charles Sébille, Michel Chérel, Françoise Kraeber-Bodéré, Thomas Carlier
Published 2019-08-01

Antitumor Immunity Induced after α Irradiation

by Jean-Baptiste Gorin, Jérémie Ménager, Sébastien Gouard, Catherine Maurel, Yannick Guilloux, Alain Faivre-Chauvet, Alfred Morgenstern, Frank Bruchertseifer, Michel Chérel, François Davodeau, Joëlle Gaschet
Published 2014-04-01

PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients

by Clément Bailly, Rodolphe Leforestier, Bastien Jamet, Thomas Carlier, Mickael Bourgeois, François Guérard, Cyrille Touzeau, Philippe Moreau, Michel Chérel, Françoise Kraeber-Bodéré, Caroline Bodet-Milin
Published 2017-02-01

64Cu-ATSM/64Cu-Cl2 and their relationship to hypoxia in glioblastoma: a preclinical study

by Elodie A. Pérès, Jérôme Toutain, Louis-Paul Paty, Didier Divoux, Méziane Ibazizène, Stéphane Guillouet, Louisa Barré, Aurélien Vidal, Michel Cherel, Mickaël Bourgeois, Myriam Bernaudin, Samuel Valable
Published 2019-12-01

Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma

by Hélène Grégoire, Loris Roncali, Audrey Rousseau, Audrey Rousseau, Michel Chérel, Yves Delneste, Yves Delneste, Pascale Jeannin, Pascale Jeannin, François Hindré, François Hindré, Emmanuel Garcion, Emmanuel Garcion
Published 2020-04-01

Immuno-PET for Clinical Theranostic Approaches

by Clément Bailly, Pierre-François Cléry, Alain Faivre-Chauvet, Mickael Bourgeois, François Guérard, Ferid Haddad, Jacques Barbet, Michel Chérel, Françoise Kraeber-Bodéré, Thomas Carlier, Caroline Bodet-Milin
Published 2016-12-01

ImmunoPET in Multiple Myeloma—What? So What? Now What?

by Clément Bailly, Benjamin Chalopin, Sébastien Gouard, Thomas Carlier, Patricia Remaud-Le Saëc, Séverine Marionneau-Lambot, Philippe Moreau, Cyrille Touzeau, Françoise Kraeber-Bodere, Caroline Bodet-Milin, Michel Chérel
Published 2020-06-01

Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model

by Marisa Capitao, Justine Perrin, Sylvain Simon, Sébastien Gouard, Nicolas Chouin, Frank Bruchertseifer, Alfred Morgenstern, Latifa Rbah-Vidal, Michel Chérel, Emmanuel Scotet, Nathalie Labarrière, Yannick Guilloux, Joëlle Gaschet
Published 2021-03-01

Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in A Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease

by Sébastien Gouard, Catherine Maurel, Séverine Marionneau-Lambot, Delphine Dansette, Clément Bailly, François Guérard, Nicolas Chouin, Ferid Haddad, Cyril Alliot, Joëlle Gaschet, Romain Eychenne, Françoise Kraeber-Bodéré, Michel Chérel
Published 2020-09-01

Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction.

by Jérémie Ménager, Jean-Baptiste Gorin, Catherine Maurel, Lucile Drujont, Sébastien Gouard, Cédric Louvet, Michel Chérel, Alain Faivre-Chauvet, Alfred Morgenstern, Frank Bruchertseifer, François Davodeau, Joëlle Gaschet, Yannick Guilloux
Published 2015-01-01

Tumor Immunotargeting Using Innovative Radionuclides

by Françoise Kraeber-Bodéré, Caroline Rousseau, Caroline Bodet-Milin, Cédric Mathieu, François Guérard, Eric Frampas, Thomas Carlier, Nicolas Chouin, Ferid Haddad, Jean-François Chatal, Alain Faivre-Chauvet, Michel Chérel, Jacques Barbet
Published 2015-02-01

What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between ⁸⁹Zr- and ⁶⁴Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Mode...

by Clément Bailly, Sébastien Gouard, François Guérard, Benjamin Chalopin, Thomas Carlier, Alain Faivre-Chauvet, Patricia Remaud-Le Saëc, Mickaël Bourgeois, Nicolas Chouin, Latifa Rbah-Vidal, Raphaël Tripier, Ferid Haddad, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Michel Chérel
Published 2019-05-01

Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of Choice

by Aurélien Corroyer-Dulmont, Aurélien Corroyer-Dulmont, Cyril Jaudet, Anne-Marie Frelin, Jade Fantin, Kathleen Weyts, Katherine A. Vallis, Nadia Falzone, Nicola R. Sibson, Michel Chérel, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Alain Batalla, Stéphane Bardet, Myriam Bernaudin, Samuel Valable
Published 2021-08-01